News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Italy Fines Novartis AG (NVS), Roche Holding AG (RHHBF.PK) $251 Million Over Eye-Drug Use


3/5/2014 8:00:25 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Italy’s antitrust regulator fined Novartis AG (NOVN) and Roche Holding AG (ROG) 182.5 million euros ($251 million) for allegedly colluding to prevent the use of Roche’s Avastin cancer drug as a treatment for an eye disease. Roche and Novartis blocked distribution of Avastin in favor of a more expensive drug, Lucentis, that the two companies market jointly for an eye malady known as wet age-related macular degeneration, the regulator said in a website statement today. Novartis must pay 92 million euros and Roche 90.5 million euros, the agency said.

Help employers find you! Check out all the jobs and post your resume.

Read at BusinessWeek
Read at Seeking Alpha
Read at New York Times
Read at Reuters
Read at Wall Street Journal


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES